Abstract
Glutathione S-transferase (GST) isoenzyme composition, isoenzyme quantities and enzymatic activity were investigated in benign (n = 4) ovarian tumours and malignant ovarian tumours, before (n = 20) and after (n = 16) chemotherapy. Enzymatic activity of GST in cytosols was measured by determining 1-chloro-2,4-dinitrobenzene conjugation with glutathione, cytosolic GST subunits were determined by wide pore reversed phase HPLC, using a S-hexylglutathione-agarose affinity column, and isoelectric focussing. Both GST activity and GST pi amount were not related to histopathologic type, differentiation grade, or tumour volume index in untreated malignant tumours. GST isoenzyme patterns were identical in benign tumours and malignant tumours before and after platinum/cyclophosphamide chemotherapy, while GST pi was the predominant transferase. Mean GST activity and GST pi amount were decreased (P < 0.05) in malignant ovarian tumours after platinum/cyclophosphamide chemotherapy compared to untreated ovarian malignant tumours. No relation was found in untreated ovarian tumours between GST pi amount and response to platinum/cyclophosphamide chemotherapy. Thus, within the limitations of the current study no arguments were found for a role of GST in in vivo drug resistance of malignant ovarian tumours to platinum/cyclophosphamide chemotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Zee, A., van Ommen, B., Meijer, C. et al. Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy. Br J Cancer 66, 930–936 (1992). https://doi.org/10.1038/bjc.1992.388
Issue Date:
DOI: https://doi.org/10.1038/bjc.1992.388
This article is cited by
-
Expression Patterns of Carcinogen Detoxifying Genes (CYP1A1, GSTP1 & GSTT1) in HNC Patients
Pathology & Oncology Research (2013)
-
Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies
Journal of Cancer Research and Clinical Oncology (2013)
-
Overcoming drug resistance in ovarian carcinoma
Current Oncology Reports (2001)
-
Factors of the ovarian cancer resistance to combined chemotherapy with platinum preparations
Bulletin of Experimental Biology and Medicine (1996)
-
Experission of glutathione-S-transferases ? and ? in gastric cancer: a correlation with cisplatin resistance
Cancer Chemotherapy and Pharmacology (1994)